Design and evolution of an enzyme with a non-canonical organocatalytic mechanism.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31132786.
- Also identified by DOI 10.1038/s41586-019-1262-8.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The combination of computational design and laboratory evolution is a powerful and potentially versatile strategy for the development of enzymes with new functions<sup>1-4</sup>. However, the limited functionality presented by the genetic code restricts the range of catalytic mechanisms that are accessible in designed active sites. Inspired by mechanistic strategies from small-molecule organocatalysis<sup>5</sup>, here we report the generation of a hydrolytic enzyme that uses N<sub>δ</sub>-methylhistidine as a non-canonical catalytic nucleophile. Histidine methylation is essential for catalytic function because it prevents the formation of unreactive acyl-enzyme intermediates, which has been a long-standing challenge when using canonical nucleophiles in enzyme design<sup>6-10</sup>. Enzyme performance was optimized using directed evolution protocols adapted to an expanded genetic code, affording a biocatalyst capable of accelerating ester hydrolysis with greater than 9,000-fold increased efficiency over free N<sub>δ</sub>-methylhistidine in solution. Crystallographic snapshots along the evolutionary trajectory highlight the catalytic devices that are responsible for this increase in efficiency. N<sub>δ</sub>-methylhistidine can be considered to be a genetically encodable surrogate of the widely employed nucleophilic catalyst dimethylaminopyridine<sup>11</sup>, and its use will create opportunities to design and engineer enzymes for a wealth of valuable chemical transformations.
Medical subject headings
- Directed Molecular Evolution
- Hydrolases
- Protein Engineering